Genomic Health, Inc. operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genomic Health with three other
pharmaceutical manufacturers in North America:
Ionis Pharmaceuticals Inc
sales of $283.70 million
of which 101%
was Ionis core),
of which 54%
was Animal Safety), and
of which 100%
During the year ended December of 2015, sales at
Genomic Health were $287.46 million.
increase of 4.3%
versus 2014, when the company's sales were $275.71 million.
This was the fifth consecutive year of sales increases at Genomic Health
(and since 2010, sales have increased a total of 61%).